These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25862183)

  • 1. Nitrosative stress but not glycemic parameters correlate with improved neuropathy in nonseverely obese diabetic patients after Roux-Y gastric bypass.
    Müller-Stich BP; Billeter AT; Fleming T; Fischer L; Büchler MW; Nawroth PP
    Surg Obes Relat Dis; 2015; 11(4):847-54. PubMed ID: 25862183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric bypass leads to improvement of diabetic neuropathy independent of glucose normalization--results of a prospective cohort study (DiaSurg 1 study).
    Müller-Stich BP; Fischer L; Kenngott HG; Gondan M; Senft J; Clemens G; Nickel F; Fleming T; Nawroth PP; Büchler MW
    Ann Surg; 2013 Nov; 258(5):760-5; discussion 765-6. PubMed ID: 23979278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting glycemia: a good predictor of weight loss after RYGB.
    Faria G; Preto J; Almeida AB; Guimarães JT; Calhau C; Taveira-Gomes A
    Surg Obes Relat Dis; 2014; 10(3):419-24. PubMed ID: 24462312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Roux-en-Y gastric bypass with different pouch size in Chinese T2DM patients with BMI 30-35 kg/m2.
    Ren Y; Yang W; Yang J; Wang C
    Obes Surg; 2015 Mar; 25(3):457-63. PubMed ID: 25236397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is sleeve gastrectomy as effective as gastric bypass for remission of type 2 diabetes in morbidly obese patients?
    de Gordejuela AG; Pujol Gebelli J; García NV; Alsina EF; Medayo LS; Masdevall Noguera C
    Surg Obes Relat Dis; 2011; 7(4):506-9. PubMed ID: 21411376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
    Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
    Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of laparoscopic Roux-en-Y gastric bypass on diabetes mellitus, hypertension and dyslipidaemia in morbidly obese patients.
    Dogan K; Betzel B; Homan J; Aarts EO; Ploeger N; de Boer H; Aufenacker TJ; van Laarhoven CJ; Janssen IM; Berends FJ
    Obes Surg; 2014 Nov; 24(11):1835-42. PubMed ID: 25027982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric bypass simultaneously improves adipose tissue function and insulin-dependent type 2 diabetes mellitus.
    Billeter AT; Vittas S; Israel B; Scheurlen KM; Hidmark A; Fleming TH; Kopf S; Büchler MW; Müller-Stich BP
    Langenbecks Arch Surg; 2017 Sep; 402(6):901-910. PubMed ID: 28691147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic control and BMI changes after endoscopic implantation of a duodenojejunal bypass liner compared with laparoscopic Roux-en-Y gastric bypass surgery: a propensity score matching analysis.
    Günthert SJ; Aksan A; Schröder O; Meyer G; Hausmann J; Stein J; Stier C
    Surg Endosc; 2022 Aug; 36(8):5979-5985. PubMed ID: 35378626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery.
    Aarts EO; Janssen J; Janssen IM; Berends FJ; Telting D; de Boer H
    Obes Surg; 2013 Jul; 23(7):867-73. PubMed ID: 23475775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
    Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T
    Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roux-en-Y gastric bypass attenuates the progression of cardiometabolic complications in obese diabetic rats via alteration in gastrointestinal hormones.
    Lau RG; Kumar S; Hall CE; Palaia T; Rideout DA; Hall K; Brathwaite CE; Ragolia L
    Surg Obes Relat Dis; 2015; 11(5):1044-53. PubMed ID: 25980330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus.
    Monte SV; Caruana JA; Ghanim H; Sia CL; Korzeniewski K; Schentag JJ; Dandona P
    Surgery; 2012 Apr; 151(4):587-93. PubMed ID: 22088821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Roux-en-Y gastric bypass or diabetes support and education on insulin sensitivity and insulin secretion in morbidly obese patients with type 2 diabetes.
    Khoo CM; Chen J; Pamuklar Z; Torquati A
    Ann Surg; 2014 Mar; 259(3):494-501. PubMed ID: 23732262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
    Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
    J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should we wait for metabolic complications before operating on obese patients? Gastric bypass outcomes in metabolically healthy obese individuals.
    Pelascini E; Disse E; Pasquer A; Poncet G; Gouillat C; Robert M
    Surg Obes Relat Dis; 2016 Jan; 12(1):49-56. PubMed ID: 26164112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel single agent for nutritional supplementation following Roux-en-Y gastric bypass.
    Brody F; Flood M; Richards NG; Vaziri K; Garey C; LeBrun C
    J Laparoendosc Adv Surg Tech A; 2013 Jul; 23(7):596-600. PubMed ID: 23651144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status.
    Blackstone R; Bunt JC; Cortés MC; Sugerman HJ
    Surg Obes Relat Dis; 2012; 8(5):548-55. PubMed ID: 22721581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy achieve comparable weight loss at 1 year.
    Yaghoubian A; Tolan A; Stabile BE; Kaji AH; Belzberg G; Mun E; Zane R
    Am Surg; 2012 Dec; 78(12):1325-8. PubMed ID: 23265120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.